Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Medtronic
McKesson
Moodys
Johnson and Johnson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Bempedoic acid

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Bempedoic acid?

Bempedoic acid is an investigational drug.

There have been 11 clinical trials for Bempedoic acid. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Hypercholesterolemia, Cardiovascular Diseases, and Atherosclerosis. The leading clinical trial sponsors are Esperion Therapeutics and [disabled in preview].

There are nine US patents protecting this investigational drug and thirty-three international patents.

Recent Clinical Trials for Bempedoic acid
TitleSponsorPhase
Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-CEsperion TherapeuticsPhase 2
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin TherapyEsperion TherapeuticsPhase 3
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor TherapyEsperion TherapeuticsPhase 2

See all Bempedoic acid clinical trials

Clinical Trial Summary for Bempedoic acid

Top disease conditions for Bempedoic acid
Top clinical trial sponsors for Bempedoic acid

See all Bempedoic acid clinical trials

US Patents for Bempedoic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bempedoic acid   Start Trial Methods of reducing risk of cardiovascular disease Gemphire Therapeutics Inc. (Livonia, MI)   Start Trial
Bempedoic acid   Start Trial Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics, Inc. (Ann Arbor, MI)   Start Trial
Bempedoic acid   Start Trial Hydroxyl compounds and compositions for cholesterol management and related uses Esperion Therapeutics, Inc. (Ann Arbor, MI)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Colorcon
Johnson and Johnson
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.